| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/01/2004 | US20040126854 Generation of transgenic microorganism coding enzymatic polypeptide with enhanced capabilities associated with lysine biosynthesis; improving animal feeds, cosmetics and pharmeceutical agents |
| 07/01/2004 | US20040126852 Comprises nucleotide sequences coding receptor binding ligand for treating obesity, cardiovascular and urogenital disorders |
| 07/01/2004 | US20040126851 Comprises nucleotide sequences coding immunoglobulin which binds chemokine receptor 2 for use in the treatment and prevention of restenosis |
| 07/01/2004 | US20040126849 Kv6.2, a voltage-gated potassium channel subunit |
| 07/01/2004 | US20040126848 Preparing methylomonas regulatory sequence for use in the expression of heterologous sequences and protein in methanotrophs; carotenoid biosynthesis |
| 07/01/2004 | US20040126847 Preparing transgenic coryneform bacterium capable of expressing industrially useful heterologous proteins such as transglutaminase; bioreactors |
| 07/01/2004 | US20040126843 Comprises nucleotide sequences coding polypeptide which regulate flower expression; improving nutrient quality of feeds for ruminant animals |
| 07/01/2004 | US20040126841 Novel G-protein coupled receptor, HLTEX11 |
| 07/01/2004 | US20040126839 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/01/2004 | US20040126838 Cell-free, in vitro method of remodeling a (FSH) peptide by deglycosylating and then contacting the truncated glycan with at least one glycosyltransferase and at least one glycosyl donor; improved properties, for its use as a therapeutic agent |
| 07/01/2004 | US20040126829 Bioassay which utilizes functionally active and soluble human leukocyte antigen for detecting antibodies which interfere in optimal allogeneic transplantation of organs, tissue and bone marrow |
| 07/01/2004 | US20040126827 Clostridium botulinum neurotoxin for treating spasticity associated with brain ischemia, or traumatic injury of the brain or spinal cord, tension hedache or pain and disorders associated with excessive release of acetylcholine for neuronal tissues |
| 07/01/2004 | US20040126824 Ovarian cancer-specific promoter |
| 07/01/2004 | US20040126819 Glial cell line-derived neurotrophic factor receptors |
| 07/01/2004 | US20040126812 Method for isolating an intestinal cholesterol binding protein |
| 07/01/2004 | US20040126811 Recombinant protein having amino acid sequence 5; medicament or diagnostic antigen |
| 07/01/2004 | US20040126810 Peptide substrate identified by type bont/b botulinus toxin and use thereof for assaying and/or detecting said toxin or corresponding inhibitors |
| 07/01/2004 | US20040126808 Small cell lung cancer associated antigens and uses therefor |
| 07/01/2004 | US20040126807 Isolated nucleic acids; polypeptides showing higher expression on cancer cells |
| 07/01/2004 | US20040126801 Novel polynucleotides and encoded polypeptides |
| 07/01/2004 | US20040126799 First nucleotide sequence comprises adenine residue at position 1033 or equivalent; reducing disease treatment side effects |
| 07/01/2004 | US20040126793 Lectin compositions and methods for modulating an immune response to an antigen |
| 07/01/2004 | US20040126787 Four groups of SCN5A variants most common in humans; tools to study mutations and design or identify new diagnostic and treatment strategies |
| 07/01/2004 | US20040126781 Methods of preventing immune-mediated abortion by inhibiting a CD28-mediated costimulatory signal |
| 07/01/2004 | US20040126777 Lp mammalian proteins; related reagents |
| 07/01/2004 | US20040126776 Gene library and a method for producing the same |
| 07/01/2004 | US20040126775 Detection of survivin in the biological fluids of cancer patients |
| 07/01/2004 | US20040126762 for drug screening lymphoma, leukemia, and carcinoma agents; monoclonal and polyclonal antibodies; ca proteins; microarrays; solid phase synthesis; kits |
| 07/01/2004 | US20040126759 Molecules for disease detection and treatment |
| 07/01/2004 | US20040126758 homologous to the known fibrinogen derived haptotactic peptides; shown to elicit activity from fibroblasts, endothelial and smooth muscle cells; for wound healing and enhancing osteogenesis/angiogenesis in vivo with/without medical implant |
| 07/01/2004 | US20040126754 reacting with the majority of anti-HCV antibodies present in patient sera; bioassays; solid phase synthesis; kits |
| 07/01/2004 | US20040126421 formed from peptide having ubiquitinatable region and antigenic region (with leukemia-/sarcoma- associated oncofusion protein breakpoint region), pH-sensitive liposomal carrier and bilayer-associated adjuvant; vaccines |
| 07/01/2004 | US20040126398 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 07/01/2004 | US20040126397 Neuromuscular disorders |
| 07/01/2004 | US20040126396 Pain therapy; administering neurotoxins |
| 07/01/2004 | US20040126395 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| 07/01/2004 | US20040126391 Meningococcal antigens |
| 07/01/2004 | US20040126390 Recombinant plasmid and a method of controlling the effects of Yersinia pestis |
| 07/01/2004 | US20040126386 Mutant proteins; induce immunology response; antitumor agents |
| 07/01/2004 | US20040126383 Administering polyclonal antibody globulin; neutralization antigens; diarrhea therapy |
| 07/01/2004 | US20040126382 Two-step immunization procedure against chlamydia infection |
| 07/01/2004 | US20040126371 Hormone polypeptides; genetic engineering; leukemia therapy |
| 07/01/2004 | US20040126364 Antiinflammatory agents; genetic engineered interleukins; oral diseases |
| 07/01/2004 | US20040126363 Cd19-specific redirected immune cells |
| 07/01/2004 | US20040126362 Anticancer agents; leukemia ; therapy, prevent of metabolism diseases |
| 07/01/2004 | US20040126357 Lectin compositions and methods for modulating an immune response to an antigen |
| 07/01/2004 | US20040124143 Suspension Cohn protein; adding reducing agent; precipitation; immobilization |
| 07/01/2004 | DE19503157B4 Instabile Insektizid-Zusammensetzungen Unstable insecticide compositions |
| 07/01/2004 | CA2840513A1 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom |
| 07/01/2004 | CA2807515A1 Alphavirus particles and methods for preparation |
| 07/01/2004 | CA2779684A1 Immunization of fish with plant-expressed recombinant proteins |
| 07/01/2004 | CA2511665A1 Endothelial cell specifically binding peptides |
| 07/01/2004 | CA2510049A1 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom |
| 07/01/2004 | CA2509825A1 Antagonists for human prolactin |
| 07/01/2004 | CA2509817A1 Forming iron nitrosyl hemoglobin |
| 07/01/2004 | CA2509694A1 Ftsz-polypeptides as a target for herbicidal compounds |
| 07/01/2004 | CA2509637A1 Bacterial strains of genus exiguobacterium, culture method and us es |
| 07/01/2004 | CA2509607A1 Cytochrome c acetylation |
| 07/01/2004 | CA2509520A1 Identification of oligonucleotides for the capture, detection and quantitation of west nile virus |
| 07/01/2004 | CA2509356A1 Glucose and/or fructose transporter naglt1 and its gene |
| 07/01/2004 | CA2509348A1 Peptides impairing pbx dependent gene regulation |
| 07/01/2004 | CA2509215A1 Method for identifying modulators of human orexin-2 receptor |
| 07/01/2004 | CA2507924A1 Thap proteins as nuclear receptors for chemokines and roles in transcriptional regulation, cell proliferation and cell differentiation |
| 07/01/2004 | CA2507915A1 Recombinant viral-based malaria vaccines |
| 07/01/2004 | CA2507817A1 Il-21 production in prokaryotic hosts |
| 07/01/2004 | CA2507387A1 Chimeric alpha q-gustducin g-proteins |
| 07/01/2004 | CA2506217A1 New expression system from rhodococcus |
| 06/30/2004 | EP1433855A2 Plasmids suitable for il-2 expression |
| 06/30/2004 | EP1433854A1 Genetically modified plant having an accelerated flowering |
| 06/30/2004 | EP1433851A2 Improved expression of HIV polypeptides and production of virus-like particles |
| 06/30/2004 | EP1433849A1 NOVEL POLYPEPTIDE, DNA THEREOF AND USE OF THE SAME |
| 06/30/2004 | EP1433848A1 Novel serine protease inhibitory protein mt0039 |
| 06/30/2004 | EP1433845A1 Clostridium tetani collagenase and uses thereof |
| 06/30/2004 | EP1433792A2 Human receptor proteins, related reagents and methods |
| 06/30/2004 | EP1433743A1 METHOD FOR PREPARING COBALT−PROTEIN COMPLEX |
| 06/30/2004 | EP1433485A2 A uro-genital condition treatment system |
| 06/30/2004 | EP1432824A2 Compositions and methods relating to prostate specific genes and proteins |
| 06/30/2004 | EP1432821A2 A method for the early detection of cancer |
| 06/30/2004 | EP1432819A2 Method for determining cell cycle position |
| 06/30/2004 | EP1432814A2 Antimicrobial methods and materials |
| 06/30/2004 | EP1432810A2 Production of recombinant proteins in vivo and use for generating antibodies |
| 06/30/2004 | EP1432806A2 A repressor-mediated regulation system for control of gene expression in plants |
| 06/30/2004 | EP1432805A2 Dna-expression construct for treatment of infections with leishmaniasis |
| 06/30/2004 | EP1432804A2 Compositions and methods relating to ovary specific genes and proteins |
| 06/30/2004 | EP1432803A2 Fragments of the human zn-alpha2-glycoprotein and their use in methods of treatment of obesity |
| 06/30/2004 | EP1432802A2 Pegylated and diglycosylated erythropoietin |
| 06/30/2004 | EP1432801A2 Receptors and membrane-associated proteins |
| 06/30/2004 | EP1432800A2 Novel nucleic acids and polypeptides |
| 06/30/2004 | EP1432794A2 Human coagulation factor vii polypeptides |
| 06/30/2004 | EP1432734A1 Cytokine receptor |
| 06/30/2004 | EP1432733A2 Gene regulatory peptides |
| 06/30/2004 | EP1432732A2 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 06/30/2004 | EP1432730A2 Glucagon-like peptide-1 analogs |
| 06/30/2004 | EP1432729A2 Peyers's patch and/or m-cell targeting ligands |
| 06/30/2004 | EP1432728A2 Methods and compositions for treating inflammatory disorders |
| 06/30/2004 | EP1432727A2 Trimeric conjugates of peptidic derivative |
| 06/30/2004 | EP1432726A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/30/2004 | EP1432722A2 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 06/30/2004 | EP1432451A2 Production of fusion proteins and use for identifying binding molecules |
| 06/30/2004 | EP1432443A2 Angiotensin peptide-carrier conjugates and uses thereof |